Stevanato Group S.p.A.

Stevanato Group S.p.A. (STVN) priced its initial public offering on Jul 16, 2021 at $21.00 per share, within its $21.00–$24.00 range, raising $672M, and listed on NYSE. At the IPO price its market capitalization was about $6.19B. UBS was lead-left underwriter. Skadden, Arps advised the company and Latham & Watkins advised the underwriters.

Stevanato Group S.p.A. provides drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It offers an integrated portfolio of products, processes and services across the drug life cycle in more than 70 countries.

Status

IPO

Ticker

STVN

Exchange

NYSE

Priced

Jul 16, 2021

IPO price

$21.00

Price range

$21.00–$24.00

Raised

$672M

Market cap at IPO price

$6.19B

First filed

Jun 21, 2021

Underwriters

UBS

Company counsel

Skadden, Arps

Underwriters' counsel

Latham & Watkins

Sector

Healthcare

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.